TREATMENT OF OVARIAN CANCER WITH NIROGACESTAT
Dossier Overview
Applicant
SpringWorks Therapeutics, Inc.
Inventor
Shinta CHENG; Todd SHEARER
IPC Classification
CPC Classification
The present disclosure relates to methods for treating ovarian cancer comprising nirogacestat or a pharmaceutically acceptable salt thereof. One embodiment is a method for treating ovarian cancer comprising administering to a patient in need thereof about 50 mg to about 600 mg per day of nirogacestat or a pharmaceutically acceptable salt thereof.
Original (Chinese)
The present disclosure relates to methods for treating ovarian cancer comprising nirogacestat or a pharmaceutically acceptable salt thereof. One embodiment is a method for treating ovarian cancer comprising administering to a patient in need thereof about 50 mg to about 600 mg per day of nirogacestat or a pharmaceutically acceptable salt thereof.
External Resources